PUMA Biotechnology, Inc. Form S-1
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
From summer lull to biotech's record-breaking month | Evaluate
Puma Biotechnology, Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
Articles with Puma Biotechnology
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Finance Watch: Biopharma IPO Market Silence Continues In The US :: Scrip
Puma Biotechnology: Too Little, Too Late, Too Much Of A Bad Side Effect (NASDAQ:PBYI) | Seeking Alpha
Institutional investors own a significant stake of 45% in Puma Biotechnology, Inc. (NASDAQ:PBYI)
DEFA14A
Puma Biotechnology - Crunchbase Company Profile & Funding
Alan H. Auerbach - Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile
Leap reverse merges, secures $30M for I/O antibodies | Fierce Biotech
Puma Biotechnology
pbyi buyout Off 77%
Gordon Esplin - Chief Accounting Officer - Puma Biotechnology, Inc. | LinkedIn
DFAN14A
Puma investors look for second lightning strike | Evaluate
pbyi buyout Off 77%
Puma Biotechnology, Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
Choice newcomers piggyback on 2012's IPO successes | Evaluate
FDA panel backs Puma's neratinib, clearing path to approval | Fierce Biotech
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology: Alisertib Deal Alters My Strategy (NASDAQ:PBYI) | Seeking Alpha
PBYI: Puma Biotechnology Inc Stock Price Quote - NASDAQ GS - Bloomberg
